The ROE as of November 2024 (TTM) for PsyBio Therapeutics Corp. (PSYBF) is -867.30%

According to PsyBio Therapeutics Corp.’s latest financial reports and current stock price. The company's current ROE is -867.30%. This represents a change of -1588.59% compared to the average of 58.26% of the last 4 quarters.

PsyBio Therapeutics Corp. (PSYBF) Historical ROE (quarterly & annually)

How has PSYBF ROE performed in the past?

The mean historical ROE of PsyBio Therapeutics Corp. over the last ten years is 98.45%. The current -867.30% ROE has changed -980.94% with respect to the historical average. Over the past ten years (40 quarters), PSYBF's ROE was at its highest in in the September 2022 quarter at 114.11%. The ROE was at its lowest in in the June 2022 quarter at -4863.05%.

PsyBio Therapeutics Corp. (PSYBF) ROE by Quarter and Year

Discovering the peaks and valleys of PsyBio Therapeutics Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PsyBio Therapeutics Corp. (PSYBF) Average ROE

How has PSYBF ROE performed in the past?

The current ROE of PsyBio Therapeutics Corp. (PSYBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PsyBio Therapeutics Corp. (PSYBF) ROE vs. Peers

How is PSYBF’s ROE compared to its peers?

PsyBio Therapeutics Corp.’s ROE is less than Health Sciences Group, Inc. (0%), less than VG Life Sciences Inc. (2.26%), less than ZIVO Bioscience, Inc. (673.84%), less than MedMira Inc. (0%), less than Oxford Cannabinoid Technologies Holdings Plc (19.53%), greater than Neurobiological Technologies, Inc. (-143.95%), less than Pharming Group N.V. (0%), less than Kane Biotech Inc. (-8.09%), greater than Nova Mentis Life Science Corp. (-64.72%), less than Awakn Life Sciences Corp. (73.69%), less than HAVN Life Sciences Inc. (175.85%), less than Tryp Therapeutics Inc. (0%), less than Mindset Pharma Inc. (131.45%), less than Regenicin, Inc. (1.01%), less than AXIM Biotechnologies, Inc. (19.74%), less than Biostage, Inc. (54.15%), greater than Wesana Health Holdings Inc. (-526.75%), less than null (242.19%),

Build a custom stock screener for PsyBio Therapeutics Corp. (PSYBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PsyBio Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PsyBio Therapeutics Corp. (PSYBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PsyBio Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.